PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 137 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $450,000 | +166.3% | 72,800 | +100.0% | 0.00% | 0.0% |
| Q1 2019 | $169,000 | -45.7% | 36,400 | -50.8% | 0.00% | 0.0% |
| Q4 2018 | $311,000 | +130.4% | 74,000 | +132.0% | 0.00% | 0.0% |
| Q2 2016 | $135,000 | +80.0% | 31,900 | +86.5% | 0.00% | – |
| Q1 2016 | $75,000 | -57.4% | 17,100 | -26.6% | 0.00% | -100.0% |
| Q4 2014 | $176,000 | -13.3% | 23,300 | -48.7% | 0.00% | 0.0% |
| Q2 2013 | $203,000 | – | 45,436 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |